BioBridgeXAll companies

CRISPR Therapeutics AG

Biotechnology company · Zug, Switzerland · Nasdaq: CRSP

CRISPR Therapeutics AG is a biotechnology company headquartered in Zug, Switzerland. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker CRSP. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

CRISPR Therapeutics at a glance

Typebiotechnology company
HeadquartersZug, Switzerland
Earliest incorporation on record2013
Stock listingNasdaq: CRSP
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1674416

What does CRISPR Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $1 million sold (2020).

Frequently asked questions about CRISPR Therapeutics

Where is CRISPR Therapeutics headquartered?

CRISPR Therapeutics AG is headquartered in Zug, Switzerland.

What does CRISPR Therapeutics do?

CRISPR Therapeutics AG is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is CRISPR Therapeutics a public company?

Yes. CRISPR Therapeutics AG trades on Nasdaq under the ticker CRSP.

When was CRISPR Therapeutics founded?

The earliest incorporation on record for CRISPR Therapeutics AG is in 2013, according to public company registers.

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.